2026
Development of the first-in-class RNF4 PROTAC degrader as potential therapeutics for hepatocellular carcinoma
Hui Wan, Yihang Liu, Huimin Chang, Kai Zhang, Zhenzhen Li, Haisen Ni, Jie Xu, Bo Pan, Kongkai Zhu, Junchi Hu, Shuai Wang, Dongqin Yang, Xiaobo Wang, Yongjun Dang, Sanyong Zhu
European Journal of Medicinal Chemistry